FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2741224768> ?p ?o ?g. }

• W2741224768 abstract "Prostate cancer (PCa) is the second most common cancer among men in the United Sates. It is estimated 1 in 6 men will be diagnosed with PCa and approximately 180,890 new cases are predicted in 2016 alone. Standard treatments for PCa include surgery, radiation, chemotherapy and hormonal therapy or a combination of these treatments. However, factors like patient health, drug resistance, specificity, and toxicity can result in poor disease prognosis. In order to overcome these limitations and improve patient prognosis, there is an urgent need to identify new anti-cancer agents with minimal side effects. Current studies are being focused on natural products and their components for alternative therapeutics. Blue Honeysuckle (Lonicera caerule L.) a berry native to northeast Asia, is known to be rich in Vitamin C and polyphenols such as anthocyanins, flavonoids, and phenolic acids. Polyphenols are found to have several therapeutic effects such as anti-inflammatory, antioxidant and antimicrobial properties. Our present study used sequential solvent extracts of Blue Honeysuckle (BHS) berry using Hexane, Ethyl Acetate, Methanol, and Water respectively. These fractions were used to assess various therapeutic effects of BHS on DU 145, PC-3, C4-2 and LNCaP PCa cell lines. The goal was to identify the most potent BHS fraction that is effective against PCa using pre-clinical studies. MTT assays were used to identify the anti-proliferative effects of various BHS fractions. The above indicated PCa cells were treated with different doses (10-150 µg/mL) of BHS factions over various time periods (24, 48, 72 hr). Our data revealed that Hexane extract (HE) exhibited the highest inhibition of cell viability in a time and dose-dependent manner. HE fraction showed to have an IC50 of 89.6 μg/mL for DU 145, 117.4 μg/mL for PC-3, 163.3 μg/mL for C4-2 and 140.84 for LNCaP cells. Moreover, BHS HE fraction showed a decrease in migration capacity and colony formation ability of PCa cells in vitro. Cellular senescence assay was performed to assess β-Galactosidase activity in PCa cells treated with BHS HE extract. All the PCa cell lines treated with 100 µg/mL of BHS HE showed increased senescence. Western blotting was performed to identify the potential anti-cancer mechanism of BHS against PCa using DU 145 and PC-3 cell lines. Results from this study indicated that DU 145 and PC-3 cell lines after 24 hr treatment with 100 μg/mL of various BHS fractions especially BHS HE showed an increase in apoptosis (Caspase 3,8,9 and PARP-1) and autophagy (LC3 A/B) markers. Furthermore, cell cycle analysis of DU 145 and PC-3 cells treated with BHS HE extract showed increased apoptotic cells. Further analysis of apoptotic and autophagy pathways modulated by BHS treatments are required to illustrate its potential underlying anti-cancer mechanisms in PCa. In conclusion, results from our study warrant further evaluation of BHS berry for potential PCa management. Citation Format: Syed M. Ali, Alex Ourth, Chun-Tao Che, Mian-Ying Wang, Gnanasekar Munirathinam. Anti-cancer evaluation of various solvent extracts of blue honeysuckle berry (Lonicera caerulea L.) against prostate cancer cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 1592. doi:10.1158/1538-7445.AM2017-1592" @default.
• W2741224768 created "2017-08-08" @default.
• W2741224768 creator A5022723017 @default.
• W2741224768 creator A5048624042 @default.
• W2741224768 creator A5056514712 @default.
• W2741224768 creator A5074246595 @default.
• W2741224768 creator A5083448314 @default.
• W2741224768 date "2017-07-01" @default.
• W2741224768 modified "2023-09-26" @default.
• W2741224768 title "Abstract 1592: Anti-cancer evaluation of various solvent extracts of blue honeysuckle berry (Lonicera caerulea L.) against prostate cancer cells" @default.
• W2741224768 doi "https://doi.org/10.1158/1538-7445.am2017-1592" @default.
• W2741224768 hasPublicationYear "2017" @default.
• W2741224768 type Work @default.
• W2741224768 sameAs 2741224768 @default.
• W2741224768 citedByCount "1" @default.
• W2741224768 countsByYear W27412247682020 @default.
• W2741224768 crossrefType "proceedings-article" @default.
• W2741224768 hasAuthorship W2741224768A5022723017 @default.
• W2741224768 hasAuthorship W2741224768A5048624042 @default.
• W2741224768 hasAuthorship W2741224768A5056514712 @default.
• W2741224768 hasAuthorship W2741224768A5074246595 @default.
• W2741224768 hasAuthorship W2741224768A5083448314 @default.
• W2741224768 hasConcept C121608353 @default.
• W2741224768 hasConcept C126322002 @default.
• W2741224768 hasConcept C142724271 @default.
• W2741224768 hasConcept C185592680 @default.
• W2741224768 hasConcept C188947578 @default.
• W2741224768 hasConcept C204787440 @default.
• W2741224768 hasConcept C2776034682 @default.
• W2741224768 hasConcept C2778004101 @default.
• W2741224768 hasConcept C2779005926 @default.
• W2741224768 hasConcept C2779723316 @default.
• W2741224768 hasConcept C2780192828 @default.
• W2741224768 hasConcept C55493867 @default.
• W2741224768 hasConcept C556039675 @default.
• W2741224768 hasConcept C59822182 @default.
• W2741224768 hasConcept C70899900 @default.
• W2741224768 hasConcept C71924100 @default.
• W2741224768 hasConcept C86803240 @default.
• W2741224768 hasConcept C98274493 @default.
• W2741224768 hasConceptScore W2741224768C121608353 @default.
• W2741224768 hasConceptScore W2741224768C126322002 @default.
• W2741224768 hasConceptScore W2741224768C142724271 @default.
• W2741224768 hasConceptScore W2741224768C185592680 @default.
• W2741224768 hasConceptScore W2741224768C188947578 @default.
• W2741224768 hasConceptScore W2741224768C204787440 @default.
• W2741224768 hasConceptScore W2741224768C2776034682 @default.
• W2741224768 hasConceptScore W2741224768C2778004101 @default.
• W2741224768 hasConceptScore W2741224768C2779005926 @default.
• W2741224768 hasConceptScore W2741224768C2779723316 @default.
• W2741224768 hasConceptScore W2741224768C2780192828 @default.
• W2741224768 hasConceptScore W2741224768C55493867 @default.
• W2741224768 hasConceptScore W2741224768C556039675 @default.
• W2741224768 hasConceptScore W2741224768C59822182 @default.
• W2741224768 hasConceptScore W2741224768C70899900 @default.
• W2741224768 hasConceptScore W2741224768C71924100 @default.
• W2741224768 hasConceptScore W2741224768C86803240 @default.
• W2741224768 hasConceptScore W2741224768C98274493 @default.
• W2741224768 hasLocation W27412247681 @default.
• W2741224768 hasOpenAccess W2741224768 @default.
• W2741224768 hasPrimaryLocation W27412247681 @default.
• W2741224768 hasRelatedWork W103243809 @default.
• W2741224768 hasRelatedWork W1966617502 @default.
• W2741224768 hasRelatedWork W2004956537 @default.
• W2741224768 hasRelatedWork W2012790773 @default.
• W2741224768 hasRelatedWork W2189325491 @default.
• W2741224768 hasRelatedWork W2323363341 @default.
• W2741224768 hasRelatedWork W2331097046 @default.
• W2741224768 hasRelatedWork W2405152921 @default.
• W2741224768 hasRelatedWork W2592690906 @default.
• W2741224768 hasRelatedWork W2594872964 @default.
• W2741224768 hasRelatedWork W2760818834 @default.
• W2741224768 hasRelatedWork W2783304365 @default.
• W2741224768 hasRelatedWork W2901579496 @default.
• W2741224768 hasRelatedWork W2920664576 @default.
• W2741224768 hasRelatedWork W2922231271 @default.
• W2741224768 hasRelatedWork W2945845659 @default.
• W2741224768 hasRelatedWork W3089077146 @default.
• W2741224768 hasRelatedWork W3182831786 @default.
• W2741224768 hasRelatedWork W868519912 @default.
• W2741224768 hasRelatedWork W2120708242 @default.
• W2741224768 isParatext "false" @default.
• W2741224768 isRetracted "false" @default.
• W2741224768 magId "2741224768" @default.
• W2741224768 workType "article" @default.